Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)-Reference-Cited by-同舟云学术

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)

Published:2024-01 Issue:1 Volume:26 Page:25-35
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Ferreras Cristina,Hernández-Blanco Clara,Martín-Quirós Alejandro,Al-Akioui-Sanz Karima,Mora-Rillo Marta,Ibáñez Fátima,Díaz-Almirón Mariana,Cano-Ochando Jordi,Lozano-Ojalvo Daniel,Jiménez-González María,Goterris Rosa,Sánchez-Zapardiel Elena,de Paz Raquel,Guerra-García Pilar,Queiruga-Parada Javier,Molina Pablo,Briones María Luisa,Ruz-Caracuel Beatriz,Borobia Alberto M.,Carcas Antonio J.,Planelles Dolores,Vicario José Luis,Moreno Miguel Ángel,Balas Antonio,Llano Marta,Llorente Andrea,del Balzo Álvaro,Cañada Carlos,García Miguel Ángel,Calvin María Elena,Arenas Isabel,Pérez de Diego Rebeca,Eguizábal Cristina,Soria Bernat,Solano Carlos,Pérez-Martínez Antonio

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference84 articles.

1. World Health Organization. Weekly epidemiological update on COVID-19. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---1-september-2023.

2. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention;Wu;JAMA.,2020

3. Analysis of fatality rates case of SARS-CoV-2 infection in the autonomous communities of Spain;Martín-Sánchez;Semergen,2020

4. Economic burden of COVID-19: a systematic review;Richards;Clin. Outcomes Res.,2022

5. Potential therapeutic options for COVID‑19 : an update on current evidence;Niknam;Eur. J. Med. Res.,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19;Seminars in Hematology;2024-08

2. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies;International Journal of Molecular Sciences;2024-07-26

3. A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection;Cytotherapy;2024-05

4. A Phase I, Dose-Escalation Clinical Trial to Evaluate the Safety of Infusing Natural Killer Cells as Adoptive Therapy in COVID-19: Release;2024